China Jo - Jo Drugstores (CJJD)
China Jo - Jo Drugstores Revenue Growth: 42.14%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
CJJD Revenue Growth Rankings
| Overall | 90th percentile | 423 of 4358 |
| Sector | 93rd percentile | 58 of 845 in Services |
| Industry | 87th percentile | 1 of 8 in Drug Stores |
CJJD Revenue Growth Range, Past 5 Years
| Minimum | 20.89% | Dec 2010 |
| Maximum | 42.14% | Dec 2011 |
| Average | 33.72% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
You may also be interested in these CJJD related companies
CJJD News
China Jo-Jo Drugstores Announces New Store Openings in Shanghai and Hangzhou
May 17, 6:39AM Benzinga
May 17, 6:39AM Benzinga
$CJJD forms bullish "Bottom Triangle" chart pattern. http://stks.co/2x6P
about 70 days ago by RecogniaEvents
about 70 days ago by RecogniaEvents
$CJJD forms bearish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/2epC
about 87 days ago by RecogniaEvents
about 87 days ago by RecogniaEvents
China Jo-Jo Drugstores Inc. Reports Financial Results for Third Quarter 2012
Feb 14, 6:00AM Business Wire
Feb 14, 6:00AM Business Wire
China Jo-Jo Drugstore expects to open approximately 15-20 new locations in FY12
Aug 15, 6:18AM FlyOnTheWall
Aug 15, 6:18AM FlyOnTheWall
China Jo-Jo Drugstores, Inc. Reports Record First Quarter 2012 Financial Results
Aug 15, 6:00AM Business Wire
Aug 15, 6:00AM Business Wire
China Jo-Jo Drugstores, Inc. Reports Fiscal 2011 Fourth Quarter and Full Year Financial Results
Jun 29, 5:28PM Business Wire
Jun 29, 5:28PM Business Wire
China Jo-Jo Drugstores Announces Fourth Quarter and Full Year Fiscal 2011 Conference Call
Jun 28, 4:40PM Business Wire
Jun 28, 4:40PM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CJJD | 0.97 | +0.00 | +0.41% | 13.12M |
| CJES | 18.58 | +0.23 | +1.25% | 964.12M |
| CIX | 13.07 | +0.07 | +0.54% | 161.94M |
| CITZ | 5.38 | +0.06 | +1.13% | 58.75M |
| CIT | 34.79 | -0.37 | -1.05% | 6.986B |
| CISG | 7.00 | -0.07 | -0.99% | 353.85M |
| CIS | 1.99 | -0.14 | -6.57% | 88.36M |
| CINF | 35.66 | +0.02 | +0.06% | 5.789B |
| CIMT | 4.314 | +0.00 | +0.04% | 42.76M |
| CIM | 2.82 | +0.03 | +1.08% | 2.897B |
